198 related articles for article (PubMed ID: 11161594)
1. Inhibition of inflammation-induced thermal hypersensitivity by sumatriptan through activation of 5-HT(1B/1D) receptors.
Bingham S; Davey PT; Sammons M; Raval P; Overend P; Parsons AA
Exp Neurol; 2001 Jan; 167(1):65-73. PubMed ID: 11161594
[TBL] [Abstract][Full Text] [Related]
2. Activation of the 5-HT1B/D receptor reduces hindlimb neurogenic inflammation caused by sensory nerve stimulation and capsaicin.
Carmichael NM; Charlton MP; Dostrovsky JO
Pain; 2008 Jan; 134(1-2):97-105. PubMed ID: 17499925
[TBL] [Abstract][Full Text] [Related]
3. Treatment with ketanserin produces opioid-mediated hypoalgesia in the late phase of carrageenan-induced inflammatory hyperalgesia in rats.
Huang J; Cai Q; Chen Y; Hong Y
Brain Res; 2009 Dec; 1303():39-47. PubMed ID: 19782054
[TBL] [Abstract][Full Text] [Related]
4. Effects of (S)-3,4-DCPG, an mGlu8 receptor agonist, on inflammatory and neuropathic pain in mice.
Marabese I; de Novellis V; Palazzo E; Scafuro MA; Vita D; Rossi F; Maione S
Neuropharmacology; 2007 Feb; 52(2):253-62. PubMed ID: 17113112
[TBL] [Abstract][Full Text] [Related]
5. The contribution of peripheral 5-hydroxytryptamine2A receptor to carrageenan-evoked hyperalgesia, inflammation and spinal Fos protein expression in the rat.
Wei H; Chen Y; Hong Y
Neuroscience; 2005; 132(4):1073-82. PubMed ID: 15857711
[TBL] [Abstract][Full Text] [Related]
6. Divergent peripheral effects of pituitary adenylate cyclase-activating polypeptide-38 on nociception in rats and mice.
Sándor K; Bölcskei K; McDougall JJ; Schuelert N; Reglodi D; Elekes K; Petho G; Pintér E; Szolcsányi J; Helyes Z
Pain; 2009 Jan; 141(1-2):143-50. PubMed ID: 19091468
[TBL] [Abstract][Full Text] [Related]
7. The local peripheral antihyperalgesic effect of levetiracetam and its mechanism of action in an inflammatory pain model.
Stepanović-Petrović RM; Micov AM; Tomić MA; Ugrešić ND
Anesth Analg; 2012 Dec; 115(6):1457-66. PubMed ID: 23144430
[TBL] [Abstract][Full Text] [Related]
8. Non-invasive assessment of selective 5-HT(1B/1D)-receptor agonist-induced peripheral vascular effects in humans: comparison of different techniques.
Vanmolkot FH; de Hoon JN; Barrington P; Peck RW; Dallow NS; Williams PM; McColm J
Eur J Clin Pharmacol; 2002 Aug; 58(5):303-8. PubMed ID: 12185552
[TBL] [Abstract][Full Text] [Related]
9. Studies with ketamine and alfentanil following Freund's complete adjuvant-induced inflammation in rats.
Edwards SR; Mather LE; Smith MT
Clin Exp Pharmacol Physiol; 2007; 34(5-6):414-20. PubMed ID: 17439409
[TBL] [Abstract][Full Text] [Related]
10. Peripherally mediated antinociception of the mu-opioid receptor agonist 2-[(4,5alpha-epoxy-3-hydroxy-14beta-methoxy-17-methylmorphinan-6beta-yl)amino]acetic acid (HS-731) after subcutaneous and oral administration in rats with carrageenan-induced hindpaw inflammation.
Bileviciute-Ljungar I; Spetea M; Guo Y; Schütz J; Windisch P; Schmidhammer H
J Pharmacol Exp Ther; 2006 Apr; 317(1):220-7. PubMed ID: 16339394
[TBL] [Abstract][Full Text] [Related]
11. Characterization of 5-HT receptor subtypes mediating contraction in human umbilical vein. 2. Evidence of involvement of 5-HT1B receptors using functional studies.
Rogines-Velo MP; Pelorosso FG; Zold CL; Brodsky PT; Rothlin RP
Naunyn Schmiedebergs Arch Pharmacol; 2002 Dec; 366(6):596-604. PubMed ID: 12444502
[TBL] [Abstract][Full Text] [Related]
12. The VR1 antagonist capsazepine reverses mechanical hyperalgesia in models of inflammatory and neuropathic pain.
Walker KM; Urban L; Medhurst SJ; Patel S; Panesar M; Fox AJ; McIntyre P
J Pharmacol Exp Ther; 2003 Jan; 304(1):56-62. PubMed ID: 12490575
[TBL] [Abstract][Full Text] [Related]
13. Antinociceptive effects of meptazinol and its isomers on carrageenan-induced thermal hyperalgesia in rats.
Wang PF; Zhang YQ; Qiu ZB; Zhao ZQ
Sheng Li Xue Bao; 2004 Jun; 56(3):295-300. PubMed ID: 15224140
[TBL] [Abstract][Full Text] [Related]
14. Involvement of pro-nociceptive 5-HT2A receptor in the pathogenesis of medication-overuse headache.
Supornsilpchai W; le Grand SM; Srikiatkhachorn A
Headache; 2010 Feb; 50(2):185-97. PubMed ID: 20039957
[TBL] [Abstract][Full Text] [Related]
15. Role of 5-HT₁B/₁D receptors in the reduction of formalin-induced nociception and secondary allodynia/hyperalgesia produced by antimigraine drugs in rats.
Godínez-Chaparro B; López-Santillán FJ; Argüelles CF; Villalón CM; Granados-Soto V
Life Sci; 2013 Jun; 92(22):1046-54. PubMed ID: 23583574
[TBL] [Abstract][Full Text] [Related]
16. Antinociceptive activity of the N-methyl-D-aspartate receptor antagonist N-(2-Indanyl)-glycinamide hydrochloride (CHF3381) in experimental models of inflammatory and neuropathic pain.
Villetti G; Bergamaschi M; Bassani F; Bolzoni PT; Maiorino M; Pietra C; Rondelli I; Chamiot-Clerc P; Simonato M; Barbieri M
J Pharmacol Exp Ther; 2003 Aug; 306(2):804-14. PubMed ID: 12750440
[TBL] [Abstract][Full Text] [Related]
17. Peripheral 5-HT2A receptor antagonism attenuates primary thermal hyperalgesia and secondary mechanical allodynia after thermal injury in rats.
Sasaki M; Obata H; Kawahara K; Saito S; Goto F
Pain; 2006 May; 122(1-2):130-6. PubMed ID: 16527395
[TBL] [Abstract][Full Text] [Related]
18. Effects of the prototype serotonin 5-HT(1B/1D) receptor agonist sumatriptan and the calcitonin gene-related peptide (CGRP) receptor antagonist CGRP(8-37) on myocardial reactive hyperemic response in conscious dogs.
Lynch JJ; Shen YT; Pittman TJ; Anderson KD; Koblan KS; Gould RJ; Regan CP; Kane SA
Eur J Pharmacol; 2009 Nov; 623(1-3):96-102. PubMed ID: 19766109
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of peripheral vanilloid TRPV1 receptors reduces noxious heat-evoked responses of dorsal horn neurons in naïve, carrageenan-inflamed and neuropathic rats.
Jhaveri MD; Elmes SJ; Kendall DA; Chapman V
Eur J Neurosci; 2005 Jul; 22(2):361-70. PubMed ID: 16045489
[TBL] [Abstract][Full Text] [Related]
20. The 5-HT(1) receptors inhibiting the rat vasodepressor sensory CGRPergic outflow: further involvement of 5-HT(1F), but not 5-HT(1A) or 5-HT(1D), subtypes.
González-Hernández A; Manrique-Maldonado G; Lozano-Cuenca J; Muñoz-Islas E; Centurión D; Maassen VanDenBrink A; Villalón CM
Eur J Pharmacol; 2011 Jun; 659(2-3):233-43. PubMed ID: 21473863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
